HUM financials
Humana Inc. · end-of-day data as of Oct 16, 2026
Humana Inc.
$413.16+6.1%
Buy · 29 analystsPT $477.98 +15.7%
HUM reported revenue of $40.87B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 26.2% from a year earlier. It posted diluted EPS of $5.72, free cash flow of -$558M and a net margin of 1.7%.
Valuation
- P/E39.1x
- P/E vs own+46.8%
- P/E vs sector+39.0%
- FCF yield-0.9%
- Market cap$49.63B
Quarterly results
Q2 FY2026: Revenue +26.2% year over year, free cash flow -1.4% of revenue, operating margin 3.3%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $40.87B | 5.72 | -$558M | 13.5% | 3.3% | 1.7% |
| Q1 FY2026 | Mar 31, 2026 | $39.65B | 9.83 | $1.13B | 15.0% | 4.0% | 3.0% |
| Q4 FY2025 | Dec 31, 2025 | $32.52B | -6.61 | -$1.85B | 11.7% | -3.2% | -2.4% |
| Q3 FY2025 | Sep 30, 2025 | $32.65B | 1.62 | $836M | 14.3% | 0.3% | 0.6% |
| Q2 FY2025 | Jun 30, 2025 | $32.39B | 4.51 | $1.16B | 14.9% | 2.2% | 1.7% |
| Q1 FY2025 | Mar 31, 2025 | $32.11B | 10.30 | $236M | 17.4% | 5.1% | 3.9% |
| Q4 FY2024 | Dec 31, 2024 | $29.21B | -5.76 | -$682M | 13.1% | -3.1% | -2.4% |
| Q3 FY2024 | Sep 30, 2024 | $29.4B | 3.98 | $1.73B | 14.5% | 2.2% | 1.6% |
| Q2 FY2024 | Jun 30, 2024 | $29.54B | 5.63 | $1.1B | 15.2% | 3.1% | 2.3% |
| Q1 FY2024 | Mar 31, 2024 | $29.61B | 6.11 | $246M | 15.2% | 3.3% | 2.5% |
| Q4 FY2023 | Dec 31, 2023 | $26.46B | -4.42 | -$7.42B | 13.9% | -2.3% | -2.0% |
| Q3 FY2023 | Sep 30, 2023 | $26.42B | 6.71 | $1.02B | 17.7% | 4.1% | 3.1% |